Search
for
Sort by
Research 331–360 of 1000+
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Alopecia areata
- Medical Therapies
- In reply
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- Hair today, gone tomorrow
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Evidence for the off-label use of tofacitinib in alopecia areata
- BH02 Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with the <i>AIRE</i> gene mutation treated with ruxolitinib
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Alopecia Universalis: Never Give Up?
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Update: baricitinib for alopecia areata
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- The usefulness and wellbeing of Tofacitinib in the treatment of Alopecia Areata
- Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Successful treatment of alopecia totalis with tofacitinib in a Danish patient
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)